Billionaire philanthropist and Microsoft co-founder Bill Gates has praised India for its vaccine-manufacturing prowess and applauded the efforts of the country's manufacturers for supplying affordable vaccines across the world.
Addressing a virtual roundtable on India-US Health Partnership organised by the Indian embassy on Tuesday, Gates noted that over the last year, India has delivered over 150 million doses of COVID-19 vaccines to nearly 100 countries.
"At the same time, thanks to Indian vaccine manufacturers, almost every country in the world now is offering vaccines to protect children from diseases such Pneumonia and Rotavirus, which have been leading causes of child's deaths for decades, Gates said.
The roundtable was organised to bring together key stakeholders in India and US for leveraging the bilateral partnership to make affordable vaccines available to the world.
While this pandemic isn't yet over, we have begun to look beyond the emergency response. This means not only controlling Covid but also being ready to stop future outbreaks before they become pandemics and continuing to fight all the infectious diseases, he explained.
In his remarks, Gates said that Prime Minister Narendra Modi has talked about deepening India's commitment to global health by continuing to harness the country's science and technology talent to advance scientific discovery and the creation of new products.
This is a shared ambition and partnerships are central to making it a reality, he said.
Gates said that the three vaccines -- Covaxin, Corbavex and Covishield - were the products of partnerships that bridge sectors as well as borders.
The Quad country partnership with Bio E. to produce over a billion vaccines is an example of how these partnerships can be scaled up to support an equitable response, he said, referring to the four-nation grouping of the US, India, Australia and Japan.
Noting that risks of COVID-19 had 'dramatically reduced', Gates warned that it was almost certain that the world will see another pandemic, for which collaborations between vaccine manufacturers was the need of the hour.
This is what makes initiatives like the developing country's vaccine manufacturers networks so exciting. Everyone involved understands that if we want to make COVID-19 the last pandemic, we need to invest now in collaborative efforts, Gates said.
We can't predict where the advances to give us better tools will come from, but we do know that our investments today will determine whether these advances come on time and whether they are ready to reach everyone who needs them, he added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU